This position affords the exciting opportunity to be part of a research effort at Dana-Farber Cancer Institute aiming to delineate genomic aberrations in cancer biology and discover novel therapeutic targets. He/she will use modern next generation sequencing techniques to characterize genomic, transcriptional and epigenetic aberrations with a heavy focus on preparing samples for next-generation sequencing and computational analysis of the resulting datasets. He/she will use various model systems to test for drug responses and determine mechanisms of resistance to drugs, including novel immunotherapies. He/she will be part of a multi-disciplinary team that evaluates new technologies and approaches to discover and validate novel systemic cancer biology.The candidate is expecte
This job listing is no longer active.
Check the left side of the screen for similar opportunities.